Johnson & Johnson Enters China’s Device Market Via Guangzhou Bioseal Biotech Acquisition
This article was originally published in PharmAsia News
J&J beefs up in China’s device market with Bioseal Biotech Acquisition
You may also be interested in...
Shiseido has strategic initiatives planned for its domestic and Chinese businesses and Bare Escentuals in the U.S. following a disappointing fiscal 2012 in which the Toyko-based firm recorded a net loss of $148 million.
La Bella, L.A. Looks and Soft & Dri have new websites and new marketing strategies behind them as Newhall Laboratories endeavors to rejuvenate personal-care brands it’s acquired over the past year and a half.